NEPHROPLUS
Nephrocare Health Services Limited (NEPHROPLUS) Stock Analysis
Nephrocare Health Services Limited operates NephroPlus, a chain of dialysis centres providing renal care services across India. It partners hospitals and runs standalone clinics with standardized clinical protocols. Growth is driven by rising chronic kidney disease and insurance coverage. It is listed on Indian stock exchanges.
Healthcare › Medical Care Facilities
₹614.40
-0.33% 1W | +31.00% 52W
Market Cap
6.2k CR
P/E Ratio
72.4
52W High
₹781.5
52W Low
₹446
Div. Yield
0%
Beta
–
50 DMA
₹692
200 DMA
₹616.2
Profit Margin
8.1%
Inst. Own.
39.8%
⚠️ BREAKDOWN
⚠️ BREAKDOWN
Fundamentals
Profit & Loss
| Metric | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|
| Sales | 197 | 219 | 228 | 246 | 260 | 266 | 282 |
| Expenses | 153 | 168 | 180 | 182 | 199 | 215 | 221 |
| Operating Profit | 44 | 51 | 48 | 64 | 61 | 51 | 60 |
| OPM % | 22% | 23% | 21% | 26% | 23% | 19% | 21% |
| Other Income | 5 | 4 | 7 | 4 | 3 | 12 | 7 |
| Interest | 5 | 6 | 6 | 45 | 6 | 3 | 2 |
| Depreciation | 18 | 19 | 20 | 23 | 22 | 26 | 25 |
| Profit before tax | 26 | 30 | 29 | -1 | 36 | 33 | 41 |
| Tax % | 24% | 17% | 17% | 1,427% | 11% | 9% | 22% |
| Net Profit | 20 | 25 | 24 | -9 | 32 | 30 | 32 |
| EPS in Rs | 19.34 | 23.91 | 13.10 | -5.24 | 3.21 | 3.03 | 3.19 |
| Metric | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|
| Sales | 286 | 318 | 437 | 566 | 756 | 999 | 1,053 |
| Expenses | 248 | 302 | 389 | 465 | 589 | 774 | 817 |
| Operating Profit | 37 | 16 | 49 | 101 | 167 | 225 | 236 |
| OPM % | 13% | 5% | 11% | 18% | 22% | 23% | 22% |
| Other Income | 5 | 10 | 6 | 8 | 14 | 23 | 26 |
| Interest | 7 | 10 | 16 | 20 | 21 | 60 | 56 |
| Depreciation | 34 | 42 | 47 | 56 | 72 | 91 | 96 |
| Profit before tax | 1 | -27 | -9 | 33 | 87 | 97 | 110 |
| Tax % | 31% | -21% | 37% | -6% | 23% | 21% | |
| Net Profit | 1 | -21 | -12 | 35 | 67 | 77 | 85 |
| EPS in Rs | 0.68 | -21.33 | -11.79 | 34.11 | 64.52 | 7.66 | 4.19 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% |
Growth — CAGR
| Metric | 3Y | 5Y | 10Y |
|---|---|---|---|
| Revenue CAGR | 32.0% | 28.0% | – |
| Profit CAGR | 103.0% | 162.0% | – |
Shareholding Pattern
Promoters63.85%
FIIs9.30%
DIIs8.10%
Public18.74%
Promoters63.85%
FIIs9.94%
DIIs8.64%
Public17.56%
Promoters63.85%
FIIs8.78%
DIIs9.05%
Public18.30%
Promoters58.32%
FIIs11.73%
DIIs8.11%
Public21.85%
Promoters63.85%
FIIs9.94%
DIIs8.64%
Public17.56%
Promoters58.32%
FIIs11.73%
DIIs8.11%
Public21.85%
NEPHROPLUS
Holdings Analysis
Key strengths & risk signals
58
Overall
66
Fundamental
51
Technical
Risks (4)
LOW MARGIN! 8.1% profit margin - thin profits.
BEARISH SENTIMENT! In last 30 days: 12 up days, 18 down days. Avg volume on up days: 219,980 vs down days: 770,227. Ratio: 0.29x
WEAK POSITION! Current price (614.4) is below both moving averages.
NEGATIVE MOMENTUM! Price declined across timeframes - down 0.3% (1 week), 16.4% (1 month), 3.4% (3 months).
Strengths (4)
PERFECT RECORD! Revenue has grown consistently every year. Exceptional business stability.
BULLISH TREND! 50-day average (692.0) is above 200-day average (616.2) - positive signal.
GOOD YEAR! Stock gained 31.0% in the last year.
OVERSOLD! RSI at 29.5 - potential bounce opportunity.
Fundamental & Technical Analysis
58Overall
66Fundamental
51Technical
Fundamental Breakdown
Growth Quality
17/30
Revenue CAGR: 33.9% (EXCELLENT, 15/15). Profit CAGR: 0% (DECLINING, 2/15).
Profit Margin
3/10
LOW MARGIN! 8.1% profit margin - thin profits.
PEG Valuation
7/10
Cannot calculate PEG - insufficient growth data.
Dividend Yield
3/10
NEGLIGIBLE DIVIDEND! 0% yield - little to no income.
Debt to Equity
10/10
VERY LOW DEBT! D/E of 0.00 - excellent financial health.
Public Holding
16/20
LESS PUBLIC HOLDING! 18.74% public ownership - good institutional/promoter control.
Stability Index
10/10
PERFECT RECORD! Revenue has grown consistently every year. Exceptional business stability.
Technical Breakdown
Moving Averages
12/10
BULLISH TREND! 50-day average (692.0) is above 200-day average (616.2) - positive signal.
Price Position
2/10
WEAK POSITION! Current price (614.4) is below both moving averages.
Trend Pattern
10/20
BREAKDOWN! Stock has broken below support levels - weakness present.
52W Performance
10/10
GOOD YEAR! Stock gained 31.0% in the last year.
Volume Sentiment
5/30
BEARISH SENTIMENT! In last 30 days: 12 up days, 18 down days. Avg volume on up days: 219,980 vs down days: 770,227. Ratio: 0.29x
RSI
5/5
OVERSOLD! RSI at 29.5 - potential bounce opportunity.
52W Range
3/5
MID RANGE! Trading at 50.2% of 52W range - neutral zone.
Momentum
1/5
NEGATIVE MOMENTUM! Price declined across timeframes - down 0.3% (1 week), 16.4% (1 month), 3.4% (3 months).
Beta
3/5
MARKET ALIGNED! Beta of 1.00 - moves with the market.
NEPHROPLUS
Concall / Investor Presentation
Earnings call transcripts & AI summaries
| Quarter | Concall | Summary |
|---|---|---|
| Q4FY262026-05-27 | Concall PDF | |
| Q3FY262026-02-18 | Concall PDF |
Peer Comparison
Healthcare · Medical Care Facilities · 8 stocks
| Stock | Price | P/E | Profit Margin | Revenue CAGR 5Y | Profit CAGR 5Y | 52W Change | Stock Strength | Trendline | YoY Profit | QoQ Profit | YoY Revenue | QoQ Revenue |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| NEPHROPLUS | ₹614.40 | 72.4 | 8.1% | 33.9% | – | +31.0% | 58 | BREAKDOWN | +35.0% | +5.3% | +23.7% | +6.1% |
| KOVAI | ₹5,973.00 | 25.9 | 15.6% | 18.2% | 28.3% | +131.8% | 70 | BREAKDOWN | +20.8% | +15.7% | +15.3% | +4.3% |
| JLHL | ₹247.10 | 44.8 | 12.0% | 18.9% | 38.6% | -20.9% | 58 | CONSOLIDATING DOWN | -14.6% | -25.9% | +16.4% | +6.0% |
| HCG | ₹588.20 | 379.5 | 0.9% | 14.6% | -22.3% | -20.0% | 55 | BREAKDOWN | +187.5% | +527.3% | +13.3% | +6.6% |
| YATHARTH | ₹992.10 | 52.8 | 13.2% | 32.0% | 38.7% | +22.3% | 84 | CONSOLIDATING UP | +12.1% | -0.8% | +51.5% | +15.0% |
| PARKHOSPS | ₹235.70 | 35.9 | 16.1% | 9.6% | 5.5% | +63.1% | 64 | BREAKDOWN | +42.2% | +16.4% | +19.3% | +3.3% |
| RAINBOW | ₹1,248.90 | 44.4 | 15.7% | 13.1% | 9.7% | -7.6% | 64 | BOUNCE FROM SUPPORT | +13.3% | -21.3% | +33.2% | +2.2% |
| JSLL | ₹388.30 | 20.5 | 27.8% | 57.7% | 87.3% | -47.5% | 63 | BREAKDOWN | +28.5% | +46.1% | +28.7% | +4.1% |
Data from TradeAlone · Updated daily
